MedWire News - Diabetes - Insulin degludec/aspart mix shows promise in phase II trial
Links shared publicly online about this topic.
- 430total visits
MedWire News - Diabetes - Insulin degludec/aspart mix shows promise in phase II trial
MedWire News A new insulin coformulation, known as IDegAsp, has shown initial promise in a proof-of-concept trial when given once daily in combination with metformin to patients with Type 2 diabetes. MedWire News
View full resource at medwire-news.md
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Insulin, Type 2 Diabetes, Glucophage, News
Most Recently Shared on March 18, 2011 at 12:56 pm By:
Insulin degludec/aspart mix shows promise in phase II trial http://bit.ly/i1hncJ #diabetes
Advertisement
